IRIS Accounts Production v24.2.0.383 02671930 Board of Directors 1.1.23 31.12.23 31.12.23 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh026719302022-12-31026719302023-12-31026719302023-01-012023-12-31026719302021-12-31026719302022-01-012022-12-31026719302022-12-3102671930ns15:EnglandWales2023-01-012023-12-3102671930ns14:PoundSterling2023-01-012023-12-3102671930ns10:Director12023-01-012023-12-3102671930ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3102671930ns10:SmallEntities2023-01-012023-12-3102671930ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3102671930ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3102671930ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3102671930ns10:FullAccounts2023-01-012023-12-3102671930ns10:Director22023-01-012023-12-3102671930ns10:CompanySecretary12023-01-012023-12-3102671930ns10:RegisteredOffice2023-01-012023-12-3102671930ns5:CurrentFinancialInstruments2023-12-3102671930ns5:CurrentFinancialInstruments2022-12-3102671930ns5:ShareCapital2023-12-3102671930ns5:ShareCapital2022-12-3102671930ns5:FurtherSpecificReserve3ComponentTotalEquity2023-12-3102671930ns5:FurtherSpecificReserve3ComponentTotalEquity2022-12-3102671930ns5:RetainedEarningsAccumulatedLosses2023-12-3102671930ns5:RetainedEarningsAccumulatedLosses2022-12-3102671930ns5:ComputerEquipment2023-01-012023-12-3102671930ns5:FurnitureFittings2022-12-3102671930ns5:ComputerEquipment2022-12-3102671930ns5:FurnitureFittings2023-01-012023-12-3102671930ns5:FurnitureFittings2023-12-3102671930ns5:ComputerEquipment2023-12-3102671930ns5:FurnitureFittings2022-12-3102671930ns5:ComputerEquipment2022-12-3102671930ns5:CostValuation2022-12-3102671930ns5:AdditionsToInvestments2023-12-3102671930ns5:ForeignExchangeDifferencesIncreaseDecreaseInInvestments2023-12-3102671930ns5:CostValuation2023-12-3102671930ns5:RetainedEarningsAccumulatedLosses2022-12-3102671930ns5:FurtherSpecificReserve3ComponentTotalEquity2022-12-3102671930ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-31
REGISTERED NUMBER: 02671930 (England and Wales)














MEDICAL INFORMATION RESEARCH
LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023






MEDICAL INFORMATION RESEARCH
LIMITED (REGISTERED NUMBER: 02671930)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 5


MEDICAL INFORMATION RESEARCH
LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Mr S G Weston Smith
Mrs K J Weston Smith



SECRETARY: Mrs K J Weston Smith



REGISTERED OFFICE: Scalands House
Brightling Road
Robertsbridge
East Sussex
TN32 5EU



REGISTERED NUMBER: 02671930 (England and Wales)



ACCOUNTANTS: Gibbons Mannington & Phipps LLP
Chartered Accountants
Landgate Chambers
Rye
East Sussex
TN31 7LJ



BANKERS: Barclays Plc
Edgbaston Business Centre
PO Box 324
38 Hayley Road
Birmingham

MEDICAL INFORMATION RESEARCH
LIMITED (REGISTERED NUMBER: 02671930)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 7
Investments 5 754,387 696,791
754,387 696,798

CURRENT ASSETS
Cash at bank 80,231 68,688

CREDITORS
Amounts falling due within one year 6 4,953 3,291
NET CURRENT ASSETS 75,278 65,397
TOTAL ASSETS LESS CURRENT
LIABILITIES

829,665

762,195

PROVISIONS FOR LIABILITIES 102,529 82,656
NET ASSETS 727,136 679,539

CAPITAL AND RESERVES
Called up share capital 100 100
Fair value reserve 7 307,587 247,969
Retained earnings 7 419,449 431,470
SHAREHOLDERS' FUNDS 727,136 679,539

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDICAL INFORMATION RESEARCH
LIMITED (REGISTERED NUMBER: 02671930)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2024 and were signed on its behalf by:





Mr S G Weston Smith - Director


MEDICAL INFORMATION RESEARCH
LIMITED (REGISTERED NUMBER: 02671930)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Medical Information Research Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on reducing balance

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

MEDICAL INFORMATION RESEARCH
LIMITED (REGISTERED NUMBER: 02671930)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2023
and 31 December 2023 791 27,837 28,628
DEPRECIATION
At 1 January 2023 791 27,830 28,621
Charge for year - 7 7
At 31 December 2023 791 27,837 28,628
NET BOOK VALUE
At 31 December 2023 - - -
At 31 December 2022 - 7 7

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 January 2023 696,791
Additions 3,596
Movement in fair value 54,000
At 31 December 2023 754,387
NET BOOK VALUE
At 31 December 2023 754,387
At 31 December 2022 696,791

The cost noted above reflects the market value of listed investments at the balance sheet date.
The historical cost of these investments is £369,762.42.

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 4,953 3,291

7. RESERVES
Fair
Retained value
earnings reserve Totals
£    £    £   

At 1 January 2023 431,470 247,969 679,439
Profit for the year 47,597 47,597
Transfers (59,618 ) 59,618 -
At 31 December 2023 419,449 307,587 727,036